DAILY PROGRAM

Plenary Lecture 1 - Carcinogenesis of Hepatocellular Carcinoma Oct. 5, 2019 (Sat) 13:50-14:30

Lecture Title
Pathological Perspective of Multistep Hepatocarcinogenesis Arising in Chronic Viral Hepatitis
Name
Young Nyun Park
Affiliation
Department of Pathology, Yonsei University College of Medicine, South Korea

 

Plenary Lecture 2 - HCV Replication and Assembly Oct. 6, 2019 (Sun) 8:30–9:10

Lecture Title
Hepatitis C Virus Replication Status: Current State of Knowledge and Remaining Questions
Name
Ralf Friedrich Wilhelm Bartenschlager
Affiliation
Department of Infectious Diseases, Heidelberg University, Germany

 

Plenary Lecture 3 - Lessons from the HIV Vaccine Development Oct. 7, 2019 (Mon) 8:30–9:10

Lecture Title
Lessons from the HIV Vaccine Development
Name
Jerome H. Kim
Affiliation
International Vaccine Institute, South Korea

 

Plenary Lecture 4 - CRISPR/Cas9 and Virus Research Oct. 8, 2019 (Tue) 8:30–9:10

Lecture Title
CRISPR Genome Editing
Name
Jin-Soo Kim
Affiliation
Institute for Basic Science, South Korea

 

Keynote Lecture 1 - Hepatocellular Carcinoma, Cirrhosis, and Pathogenesis Oct. 5, 2019 (Sat) 14:30-15:00

Lecture Title
Genomic Alterations in Liver Cancer Associated with HCV Infection
Name
Ju-Seog Lee
Affiliation
Department of Systems Biology, University of Texas MD Anderson Cancer Center, USA

 

Keynote Lecture 2 - Viral Life Cycle I (Entry and Replication) Oct. 6, 2019 (Sun) 10:40-11:10

Lecture Title
Hepatitis C Virus Cell Entry and Pathogenesis of Liver Disease
Name
Thomas F. Baumert
Affiliation
Hepatology at the Center for Digestive Disease, University of Strasbourg, France

 

Keynote Lecture 3 - Viral Life Cycle II (Assembly and Virus-Host Interaction) Oct. 6, 2019 (Sun) 14:00-14:30

Lecture Title
HCV Pit Stop at the Lipid Droplet: Refuel Lipids and Put on a Lipoprotein Coat before Exit
Name
Thomas Pietschmann
Affiliation
Institute for Experimental Virology, Germany

 

Keynote Lecture 4 - Innate and Adaptive Immune Responses Oct. 7, 2019 (Mon) 10:40 - 11:10

Lecture Title
Correlates of Protective Immunity against HCV
Name
Naglaa Shoukry
Affiliation
Université de Montréal, Canada

 

Keynote Lecture 5 - Emerging and Related Viruses Oct. 7, 2019 (Mon) 14:00 - 14:30

Lecture Title
Beyond Hepatitis C Virus: Novel Insights into Acute and Chronic Hepatitis Virus Infections
Name
Alexander Ploss
Affiliation
Princeton University, USA

 

Keynote Lecture 6 - Vaccines and New Antiviral Agents Oct. 8, 2019 (Tue) 9:10-9:40

Lecture Title
Results of the First Prophylactic HCV Vaccine Efficacy Trial
Name
Andrea Cox
Affiliation
Johns Hopkins School of Medicine, USA

 

Keynote Lecture 7 - Enteric Hepatitis Viruses (HAV and HEV) Oct. 8, 2019 (Tue) 10:40-11:10

Lecture Title
New Insights into Hepatitis E Virus Biology and Pathogenesis
Name
Christopher M. Walker
Affiliation
The Research Institute at Nationwide Children's Hospital, USA

 

Keynote Lecture 8 - Issues in DAA Treatments Oct. 8, 2019 (Tue) 14:00-14:30

Lecture Title
HCV Therapy: Solutions Found, What’s Next?
Name
Jean-Michel Pawlotsky
Affiliation
Medicine at the University of Paris-Est, France

 

Keynote Lecture 9 - HCV: 30 Years and Future Oct. 8, 2019 (Tue) 16:00 -16:30

Lecture Title
HCV: 30 Years of Progress and Into the Future
Name
T. Jake Liang
Affiliation
National Institutes of Health, USA

 

Special Lecture 1 - Hepatocellular Carcinoma, Cirrhosis, and Pathogenesis Oct. 5, 2019 (Sat) 16:00-16:30

Lecture Title
Recent Progress in the HCC Treatment
Name
Seung Kew Yoon
Affiliation
The Catholic University of Korea, South Korea

 

Special Lecture 2 - HCV: 30 Years and Future Oct. 8, 2019 (Tue) 16:15-16:45

Lecture Title
Current Status and Future Control of HCV Infection in South Korea
Name
Sook-Hyang Jeong
Affiliation
Seoul National University, South Korea